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Introduction
According to an hypothesis of M under et al. *, lysolecithin may be viewed at as an adjuvant-induc ed endogenic m ediator of immune reactions in vivo. Subsequently it has been found that lysolecithin it self possesses the properties of an immunological adjuvant in vivo as well as in v i tr o 2' 3. Synthetic lysolecithin analogs 4~7, designed to be resistant to metabolism by membrane associated enzymes such as lysophospholipase or acyl CoA : lysolecithin acyltransferase8 exhibited a sim ilar o r even stronger adjuvanticity than the natural com pound9. More over, shortening the hydrophobic chain of lyso lecithin from 16 or 18 to 10 or 12 carbon atoms resulted in analogs possessing significant immuno suppressive activity 10.
The molecular and cellular events responsible for these observed effects are not yet understood. Since lysolecithin and some analogs, however, are known to be highly surface-and membrane-active sub stances 12, one might expect that the effects de scribed above are initiated by a physical interRequests for reprints should be sent to Dr. H. U. Weltzien, Max-Planck-Institut für Immunbiologie, D-7800 Freiburg, Stübeweg 51. action of the lysophosphatide molecules with the plasma membranes of cells involved in immune reactions. In fact, it has been shown in a previous study that long-and short-chain lysolecithin analogs have different effects upon the process of junction formation between stimulated and non stimulated lym phocytes13. Furtherm ore, it has been demon strated that at subtoxic concentrations lysophos phatides interfere with the agglutination of chicken erythrocytes by Con A, but not with that of bovine or human red cells 14»15. It was then concluded15 that these effects must be due to cellspecific surface alterations induced by lysolecithin. In an attempt to relate such membrane changes to the immuno logical activity of lysophosphatides, the present study was designed to determine whether lyso lecithin altered the agglutionation behaviour also of thymus cells.
M aterials and M ethods

L ysophosphatides
L-lysolecithin was purchased from C. Roth OHG, Karlsruhe, Germany, and will be called " natural lysolecithin" or "lysolecithin" in the course of this paper. Lysolecithin-analogs were synthesized ac cording to methods published elsewhere 6. The pre paration of lysophosphatides labelled with 14C in the choline methyl-groups has also been described b e fo re 7, as well as solubilization and storage con ditions for these compounds 15,16.
Buffers
Phosphate buffered saline contained 8.1 m M N a2H P 0 4 , 1.5 m M KH2P 0 4 , 137 m M NaCl, 3.4 m M KC1, 0.9 m M CaCl2 and 0.5 m M MgCl2 , pH 7.2. Eagle's medium was prepared as described by Smith et al. 17 .
Cells
Thymocytes were prepared by homogenizing small pieces of calf or rabbit thymi in a loose fitting Tenbroek tissue grinder (glass) in Eagle's medium. The homogenates were filtered through nylon wool to remove aggregates and connective tissue and were then incubated for 30 min at 37 °C on a nylon fibre column (leucopac) in Eagle's medium to remove dead cells. After elution from the column the cells were centrifuged once at 1200 rpm and resuspended either in phosphate buffered saline or in Eagle's medium at a cell density of 1.5 x 108 cells per ml. The proportion of trypan blue positive cells was usually between 5 and 15%.
Erythrocytes were isolated by centrifugation of citrate stabilized whole blood which had been stored at 4 °C no longer than 5 days. After 3 washes with saline the cell sediment was diluted 1 :50 in phosphate buffered saline for agglutination assays. Trypsin digestion of red cells was carried out as described e a rlie r10 using 0.4 mg trypsin (Boehringer/M annheim , lyophilized) and about 5 x l 0 8 cells per ml in phosphate buffered saline for 30 min at 37 °C. The cells were subsequently centrifuged, re suspended in saline containing 0.25 mg trypsin inhibi tor (from eggwhite, Boehringer/M annheim) per ml, washed twice with buffer, and then resuspended at a 1 :5 0 dilution in phosphate buffered saline.
A gglutination assay
Con A agglutination experiments with thymocytes were carried out as described earlier for red cell agglutination15, except that the test volume was reduced to 0.5 ml. In brief: The cell suspensions were kept shaking in 10 ml glass vessels in a 37 °C waterbath. At various times after the addition of Con A samples were removed and examined under a microscope. A gglutination was scored according to the num ber and size of agglutinates from -to -f + + + (see Fig. 2 ). Lysophosphatides were ad ded at various concentrations 5 min prior to the a d dition of Con A.
Binding of 3H -labelled ConA to thym ocytes 6 x 1 0 " cells in 0.5 ml phosphate buffered saline were mixed with 0.5 ml of 3H-labelled ConA (2.58 x l 0 5 cpm/mg protein) at various concentrations. After 45 min at 23 °C the cells were centrifuged, and the sediments washed twice with 1 ml of the same buffer. The pellets were then transferred to scintillation vessels, oxidized by H 20 2 in 1 ml of isopropanol/soluene (Packard) (1 :1 , v/v) at 40 °C and dissolved in 10 ml of scintigel (C. Roth, Karls ruhe, Germ any). The radioactivity was determined in a liquid scintillation counter (Tricarb 3000, P ackard).
Binding of u C-labelled phosphatides to cells
The detailed procedure has been described pre viously16. In short: Cells were mixed with the radioactive lipids in phosphate buffered saline under conditions identical to those used for agglutination assays. After 30 min at 37 °C, the cells were centri fuged, and the radioactivity was determined in the supernatant and in the pellet.
Concanavalin A ( Con A )
C onA was obtained from Miles Yeda (2 x crys tallized, in saturated NaCl) and stored at 4 °C. The 3H-labelled C onA was generous gift of Dr. M. Inbar at the Weizmann Institute of Science, Rehovot, Israel. The hapten-inhibitor a-methyl-Dmannopyranoside was purchased from C. Roth, K arlsruhe, Germany.
Results
A gglutination of th ym ocytes b y concanavalin A ( Con A )
Thymus cells derived from calf or rabbit were effectively agglutinated by Con A at concentrations as low as 2 //g Con A/ml. Thus, both kinds of cells were agglutinated by lower ConA concentrations and more rapidly than for instance chicken red cells or trypsinized hum an or bovine erythrocytes15-Self-agglutination of thymocytes in the absence of C onA was negligible within 15 -20 min. N atural lysolecithin as well as the desoxy-analog ET16-H are highly surface active and hemolytic substances, while ET 12 -H exhibits a lower surface activity and is substantially less hemolytic towards red cells 6. Ether-desoxy lysolecithin analogs, rather than L-lysolecithins of varying chain length in the acyl residues, were used because these phosphatides are metabolized by neither lysophospholipases nor acyltransferases. Such compounds thus remain un altered within cellular membranes for a long period of tim e 15, whereas L-lysolecithin is metabolized quite rea d ily 8. In immunological experiments per formed by Langer et a / . 1018 ET16 -H as well as natural lysolecithin have been found to possess strong adjuvant properties, in contrast to E T 12 -H and other short chain analogs, which can significant ly suppress hum oral immune responses in mice 10,18.
Lysophosphatides
Effects of lysophosphatides on the Con A in duced agglutination of thym us cells
To determine the effects of lysophosphatides on the Con A agglutination of thymocytes, cells were preincubated for 5 min at 37 °C with various amounts of lysolecithin, ET16 -H or ET12 -H. After this time, phosphatide adsorption to the cells had come to an equilibrium , as determined by the use of 14C-labelled analogs. The toxicity of the phosphatides towards thymus cells was checked by the trypan blue method. It was found that lyso lecithin and E T 16 -H up to concentrations of 10 nmol/ml, and E T 12 -H up to 100 nmol/ml did not change the proportion of cells which could be stained with trypan blue. Table I presents the kinetics of the agglutination by 2 /tg Con A/ml of thymus cells pretreated with long chain lysophosphatides in comparison to un treated control cells. It may be seen that low phos phatide concentrations resulted in a slight accelera tion of the agglutination rates.
In general, the effects of lysolecithin and ET16 -H on thymocyte agglutination are rather weak when com pared to their effects on ConAagglutination of erythrocytes15. This may be at tributed to the fact that thymocytes apparently are already close to a state of optimal agglutinability. The small differences shown in Table II thus call for a definition of our standards for agglutination readings. These standards, as they appear in darkfield microscopy, are shown in Fig. 2 *. It may be seen there, that using this visual method, a dif ference of one + in the readings represents about the limit of significance. Greater differences, how ever, are absolutely clearcut.
In contrast to the results obtained with long chain phosphatides, pretreatm ent of thymocytes with the short chain E T 12 -H led to highly signi ficant -though adverse -effects on their Con A agglutinability. As is dem onstrated in Table II, ET12 -H at a concentration above 40 nmol/ml, when about 7 -10 nmol E T 12 -H are adsorbed per 108 cells, inhibited almost completely the agglutina tion of thymocytes from both animal species. Again, these phosphatide concentrations were not toxic to the cells as determined with trypan blue. At lower concentrations ET12 -H had virtually no effect on thymocyte agglutination.
It should be noted here, that the affinity of the C12-compound to cell surfaces is significantly lower than that of the C16-analog 19, so that only 20% or less of the ET12 -H added, but more than 80% of the ET16 -H is bound to the cells. Thus, addition of 40 nmol ET12 -H or of 10 nmol ET 16 -H (or ES16 -OH) leads in either case to the binding of 8 -9 nmol to the cells. W ith respect to lysophosphatide-binding, calf and rabbit thymocytes are in distinguishable.
The results of Tables II and III , obtained in phosphate buffered saline, were essentially the same when the agglutinations were perform ed in Eagle's medium with or without serum. Some data for the agglutination of rabbit thymocytes in Eagle's me dium containing 10% fetal calf serum are shown in Table III . In this medium the adsorption of ET16 -H to the cells was reduced by about 60%, that of ET12 -H by about 30%, probably because of competing adsorption of the phosphatides to serum lipoproteins.
Effects of E T 12 -H on red cell agglutination
Experiments with 4 different species of red cells were performed to decide whether the observed inhibiting effect of ET12 -H on thymocyte agglu tination represented a general phenomenon, or if there existed differences between different cells. The results shown in sinized bovine erythrocytes, a a minimal concentra tion of 120 nmol/ml. The effects of long chain lyso lecithin analogs -including ET1(J -H on the Con A induced agglutination of various red cells has been published previously 14r 15.
Binding of Con A to thym ocytes
The binding of tritium-labelled Con A to calf thymocytes was measured using untreated cells (control) as well as cells pretreated with either 3.3 nmol ET 16 -H or 100 nmol ET12 -H per 1.5 X 108 cells (6 x 10" cells/m l). These are conditions which, as shown above, enhance or inhibit, respecti vely, the agglutination of thymocytes by Con A. The results of these experiments are shown in Figs 3 a and 3 b. Fig. 3 a represents a linear plot of specifi cally bound Con A, i. e. total binding minus Con A bound in the presence of 0.4 M a-methyl-D-mannopyranoside, versus the am ount of Con A added. It is clear from these curves that neither phosphatide significantly affected the binding of Con A to the cells. This result is more pronounced, when the data are plotted according to Scatchard20 (Fig. 3 b ) . W ithin the range of error, all values fit one curve, which extrapolates to a maximal binding of about which is in good agreement with the value of 1.2 x 107 l/mol published by Bethel and van den Berg 21 for the binding constant of Con A to rat lymphnode-and thymus-cells.
D iscussion
The mechanism of Con A induced cell agglutina tion is not yet well understood. It is apparent, how ever, that the agglutinability of a certain cell type is not determined simply by the num ber of Con Abinding sites on its surface 22" 2S. Moreover, evidence is increasing which implies that the m obility of Con A membrane receptors is a critical param eter in determining the degree of cell agglutination by this lectin 24_26, supporting the original concept of Sachs27 and N icolson28. Since lateral m otion of membrane receptors is only possible in sufficiently fluid m em branes29, our previously reported find in g 14" 15 that changes of the lysolecithin con centration in certain red cells result in an alteration of their Con A agglutinability, may lend further support to the idea of receptor mobility as a prerequisit for cell agglutination by Con A.
As was demonstrated by the results presented in Tables I to III , also the agglutination behaviour of thymocytes with Con A can be influenced by ad sorption of lysophosphatides, most likely to their plasma membranes. Studies on the Con A-binding to thymocytes (Fig. 3 ) , in agreement with our re sults on the binding of Con A to red cells 15, ex cluded the possibility of lysolecithin induced changes in the num ber and affinity of lectin-receptors as well as functional alterations of the Con A molecules. Following my previous argum entation15, I therefore believe that also in the thymocyte system an altered receptor-mobility or -distribution, due to changes in the membrane lipid composition, pre sently provides the simplest explanation for the ob served effects.
In this context it is im portant to recall that all phospholipids tested so far (see Table IV and ref. 15) exhibit different effects on different cells. This is demonstrated particularly by the results obtained with red cells and thymocytes from the same animal species (see data on rabbit thymocytes in Table II and rabbit erythrocytes, Table IV ). From this it may be inferred that lysophosphatides injected into animals may well induce rather sepcific alterations in only a limited num ber of cell types. Moreover, the previous notion 15 that structural differences of lyso lecithin analogs may be reflected in different su r face alterations, has been corroborated by the re sults obtained here with long-and short-chain desoxy-lysolecithins. It is of particular interest, that thymocytes especially respond differently to treat ment with ET16 -H or with ET12 -H, phosphatides which have been found to act as adjuvant or im munosuppressant, respectively lft> 18.
As mentioned before, these membrane alterations may be viewed as changes in the mobility of mem brane receptors. It should be stated clearly, how ever, that direct evidence for this latter hypothesis is yet lacking, and that other explanations such as lysolecithin induced conformational changes of membrane proteins, alterations of the net surface charge, stimulation or inactivation of m embrane enzymes, and probably other factors can not be ex cluded at the present time.
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